{"id":"https://openalex.org/W2286731599","doi":"https://doi.org/10.1080/23723556.2015.1033095","title":"Rational targeting of BRAF and PI3-Kinase signaling for melanoma therapy","display_name":"Rational targeting of BRAF and PI3-Kinase signaling for melanoma therapy","publication_year":2015,"publication_date":"2015-05-07","ids":{"openalex":"https://openalex.org/W2286731599","doi":"https://doi.org/10.1080/23723556.2015.1033095","mag":"2286731599","pmid":"https://pubmed.ncbi.nlm.nih.gov/27314067","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4909456"},"language":"en","primary_location":{"id":"doi:10.1080/23723556.2015.1033095","doi":"https://doi.org/10.1080/23723556.2015.1033095","is_oa":true,"landing_page_url":"https://doi.org/10.1080/23723556.2015.1033095","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/23723556.2015.1033095?needAccess=true&role=button","source":{"id":"https://openalex.org/S2764839827","display_name":"Molecular & Cellular Oncology","issn_l":"2372-3548","issn":["2372-3548","2372-3556"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular & Cellular Oncology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.tandfonline.com/doi/pdf/10.1080/23723556.2015.1033095?needAccess=true&role=button","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041887233","display_name":"Marian M. Deuker","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marian M. Deuker","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003652463","display_name":"Martin McMahon","orcid":"https://orcid.org/0000-0003-2812-1042","observed_orcids":["https://orcid.org/0000-0003-2812-1042"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]},{"id":"https://openalex.org/I4210167126","display_name":"UCSF Helen Diller Family Comprehensive Cancer Center","ror":"https://ror.org/05yndxy10","country_code":"US","type":"facility","lineage":["https://openalex.org/I180670191","https://openalex.org/I4210110664","https://openalex.org/I4210167126"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Martin McMahon","raw_affiliation_strings":["Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helen Diller Family Comprehensive Cancer Center and Department of Cell and Molecular Pharmacology, University of California, San Francisco, CA, USA","institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5003652463"],"corresponding_institution_ids":["https://openalex.org/I180670191","https://openalex.org/I4210167126"],"apc_list":{"value":1250,"currency":"GBP","value_usd":1590},"apc_paid":null,"fwci":0.2359,"has_fulltext":true,"cited_by_count":6,"citation_normalized_percentile":{"value":0.52776181,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":94},"biblio":{"volume":"3","issue":"3","first_page":"e1033095","last_page":"e1033095"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11533","display_name":"Melanoma and MAPK Pathways","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12104","display_name":"Protein Tyrosine Phosphatases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/braf-mutant-melanoma","display_name":"BRAF-mutant melanoma","score":0.9610000252723694},{"id":"https://openalex.org/keywords/pi3k-inhibition","display_name":"PI3K inhibition","score":0.8140000104904175},{"id":"https://openalex.org/keywords/mapk-pathway-inhibitors","display_name":"MAPK pathway inhibitors","score":0.8669999837875366},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.9700000286102295},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8799999952316284},{"id":"https://openalex.org/keywords/targeted-cancer-therapy","display_name":"targeted cancer therapy","score":0.6489999890327454}],"concepts":[{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.7538881897926331},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.7092128992080688},{"id":"https://openalex.org/C184235292","wikidata":"https://www.wikidata.org/wiki/Q421851","display_name":"Kinase","level":2,"score":0.6432391405105591},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5895832180976868},{"id":"https://openalex.org/C97029542","wikidata":"https://www.wikidata.org/wiki/Q281417","display_name":"Protein kinase A","level":3,"score":0.5062488913536072},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.478786826133728},{"id":"https://openalex.org/C53345823","wikidata":"https://www.wikidata.org/wiki/Q5531554","display_name":"Gene isoform","level":3,"score":0.45565274357795715},{"id":"https://openalex.org/C132149769","wikidata":"https://www.wikidata.org/wiki/Q899651","display_name":"Mitogen-activated protein kinase","level":3,"score":0.4343973398208618},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.21818989515304565},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15773308277130127},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.10559731721878052}],"mesh":[],"locations_count":4,"locations":[{"id":"doi:10.1080/23723556.2015.1033095","doi":"https://doi.org/10.1080/23723556.2015.1033095","is_oa":true,"landing_page_url":"https://doi.org/10.1080/23723556.2015.1033095","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/23723556.2015.1033095?needAccess=true&role=button","source":{"id":"https://openalex.org/S2764839827","display_name":"Molecular & Cellular Oncology","issn_l":"2372-3548","issn":["2372-3548","2372-3556"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular & Cellular Oncology","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3875647","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4909456","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4909456","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4909456","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Mol Cell Oncol","raw_type":"Text"},{"id":"pmid:27314067","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27314067","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular & cellular oncology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1080/23723556.2015.1033095","doi":"https://doi.org/10.1080/23723556.2015.1033095","is_oa":true,"landing_page_url":"https://doi.org/10.1080/23723556.2015.1033095","pdf_url":"https://www.tandfonline.com/doi/pdf/10.1080/23723556.2015.1033095?needAccess=true&role=button","source":{"id":"https://openalex.org/S2764839827","display_name":"Molecular & Cellular Oncology","issn_l":"2372-3548","issn":["2372-3548","2372-3556"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","norway-1","poland-20","russia-white-list-3","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Molecular & Cellular Oncology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9391000270843506}],"study_designs":[],"awards":[{"id":"https://openalex.org/G9000872090","display_name":"Targeting Oncogenic NRAS, BRAF plus PI3'-Kinase Signaling for Melanoma Therapy","funder_award_id":"R01CA176839","funder_id":"https://openalex.org/F4320337351","funder_display_name":"National Cancer Institute"}],"funders":[{"id":"https://openalex.org/F4320337351","display_name":"National Cancer Institute","ror":"https://ror.org/040gcmg81"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2286731599.pdf","grobid_xml":"https://content.openalex.org/works/W2286731599.grobid-xml"},"referenced_works_count":10,"referenced_works":["https://openalex.org/W1970195561","https://openalex.org/W2060317877","https://openalex.org/W2087693130","https://openalex.org/W2090420216","https://openalex.org/W2100048003","https://openalex.org/W2100614336","https://openalex.org/W2105660237","https://openalex.org/W2156918228","https://openalex.org/W2167009545","https://openalex.org/W2167059308"],"related_works":["https://openalex.org/W2136938899","https://openalex.org/W2322808366","https://openalex.org/W6980493470","https://openalex.org/W2508665420","https://openalex.org/W1561755980","https://openalex.org/W2620403292","https://openalex.org/W2969491369","https://openalex.org/W4220864307","https://openalex.org/W2890752806","https://openalex.org/W1435076864"],"abstract_inverted_index":{"Although":[0],"mitogen-activated":[1],"protein":[2],"kinase":[3],"(MAPK)":[4],"inhibitors":[5],"elicit":[6],"initial":[7],"regression":[8],"of":[9,29,45],"BRAF-mutated":[10,30],"melanoma,":[11,31],"drug":[12],"resistance":[13],"is":[14],"an":[15],"inevitable":[16],"and":[17],"fatal":[18],"event.":[19],"We":[20],"recently":[21],"reported":[22],"that":[23],"in":[24],"genetically":[25],"engineered":[26],"mouse":[27],"models":[28],"isoform-selective":[32],"phosphatidylinositol":[33],"3-kinase":[34],"inhibition":[35,40],"cooperates":[36],"with":[37],"MAPK":[38,46],"pathway":[39,47],"to":[41],"forestall":[42],"the":[43],"onset":[44],"inhibitor":[48],"resistance.":[49]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":1}],"updated_date":"2026-11-06T12:05:46.655746","created_date":"2016-06-24T00:00:00"}